Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding IT:ARKG?
Track your performance easily
IT:ARKG Price & Analysis
ARKG ETF Chart & Stats
Day’s Range― - ―
52-Week Range€3.81 - €4.78
Previous Close€4.25
VolumeN/A
Average Volume (3M)4.52K
AUM3.79M
NAV4.12
Expense Ratio0.79%
Holdings Count36
Beta0.56
Inception DateApr 12, 2024
Next Dividend Ex-DateN/A
Dividend Yield
(―)Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume4,516
AlphaN/A
Ark Genomic Revolution Ucits ETF AccumUSD (ARKG) Fund Flow Chart
Ark Genomic Revolution Ucits ETF AccumUSD (ARKG) 1 year Net Flows: €3M
ARKG ETF News
ARKG ETF FAQ
What was IT:ARKG’s price range in the past 12 months?
IT:ARKG lowest ETF price was €3.81 and its highest was €4.78 in the past 12 months.
What is the AUM of IT:ARKG?
As of Dec 19, 2024 The AUM of IT:ARKG is 3.79M.
Is IT:ARKG overvalued?
According to Wall Street analysts IT:ARKG’s price is currently Undervalued.
Does IT:ARKG pay dividends?
IT:ARKG does not currently pay dividends.
How many shares outstanding does IT:ARKG have?
Currently, no data Available
Which hedge fund is a major shareholder of IT:ARKG?
Currently, no hedge funds are holding shares in IT:ARKG
ARKG ETF Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Twist Bioscience
8.87%
Crispr Therapeutics
6.95%
Recursion Pharmaceuticals, Inc
6.55%
Natera Inc.
5.50%
Adaptive Biotechnologies
5.46%
CareDx Inc
4.83%
Veracyte Inc
4.82%
Beam Therapeutics, Inc.
4.57%
Guardant Health
4.31%
Schrodinger, Inc.
4.09%
Total55.96%
ETF Description
Ark Genomic Revolution Ucits ETF AccumUSD
The investment objective of the Fund is to generate long term capital growth (5 years or more)